scholarly journals Effects of protein phosphatase inhibitors on the regulation of insulin-sensitive enzymes within rat epididymal fat-pads and cells

1991 ◽  
Vol 276 (3) ◽  
pp. 649-654 ◽  
Author(s):  
G A Rutter ◽  
A C Borthwick ◽  
R M Denton
Keyword(s):  
Okadaic Acid ◽  
Pyruvate Dehydrogenase ◽  
Protein Phosphatase ◽  
Acid Treatment ◽  
Acetyl Coa Carboxylase ◽  
Acetyl Coa ◽  
Phosphatase Inhibitors ◽  
Epididymal Fat ◽  
Protein Phosphatase Inhibitors ◽  
Fat Pads

1. The effects of the protein phosphatase inhibitors okadaic acid and microcystin LR on the regulation by insulin of pyruvate dehydrogenase and acetyl-CoA carboxylase have been studied in rat epididymal fat-pads and isolated cells. These inhibitors both completely blocked the phosphatase activity (against phosphorylase a) present in extracts of epididymal fat-pads, with half-maximal effects in the nanomolar range. 2. Okadaic acid treatment of pads and cells lowered the activity of acetyl-CoA carboxylase assayed in tissue extracts, both before and after treatment of the extracts with the activator, citrate. Further, okadaic acid treatment abolished the 2-3-fold difference in activity observed between extracts from control and insulin-treated tissues, assayed without prior treatment with citrate. 3. Incubation of pads with [32P]Pi, sufficient to label the intracellular pool of ATP, demonstrated that okadaic acid increased the overall phosphorylation of acetyl-CoA carboxylase on a number of distinct sites, as judged by two-dimensional mapping of tryptic peptides. These included the ‘I-peptide’ [Brownsey & Denton (1982) Biochem. J. 202, 77-86], the phosphorylation of which may be associated with the stimulation of the activity of the enzyme by insulin, as well as inhibitory phosphorylation sites. 4. Incubation with 1 microM-okadaic acid had no effect on the basal level of active pyruvate dehydrogenase apparent after tissue extraction, but abolished the 2-3-fold increase in this parameter which was elicited by insulin in the absence of okadaic acid. However, okadaic acid treatment did not affect the persistent increase in active pyruvate dehydrogenase levels which was apparent in mitochondria subsequently isolated from insulin-treated pads and re-incubated with an oxidizable substrate. It is concluded that the effects of okadaic acid are exerted through changes in metabolite concentrations rather than some direct action on the signalling pathway whereby insulin stimulates pyruvate dehydrogenase. 5. Microcystin LR did not mimic the effects of okadaic acid on intact cells and pads described above.

scholarly journals Coenzyme A is a potent inhibitor of acetyl-CoA carboxylase from rat epididymal fat-pads

1992 ◽  
Vol 283 (1) ◽  
pp. 35-38 ◽  
Author(s):  
S K Moule ◽  
N J Edgell ◽  
A C Borthwick ◽  
R M Denton
Keyword(s):  
Potent Inhibitor ◽  
Ion Exchange Chromatography ◽  
Exchange Chromatography ◽  
Acetyl Coa Carboxylase ◽  
Inhibitory Effects ◽  
Fat Pad ◽  
Maximal Inhibition ◽  
Acetyl Coa ◽  
Epididymal Fat ◽  
Fat Pads

Rat epididymal fat-pad extracts have previously been shown to contain an insulin-stimulated acetyl-CoA carboxylase kinase, which is co-eluted from Mono Q ion-exchange chromatography with a potent inhibitor of acetyl-CoA carboxylase [Borthwick, Edgell & Denton (1990) Biochem. J. 270, 795-801]. A variety of tests, including reactivity with thiol reagents, identify this inhibitor as CoA. Inhibition requires the presence of MgATP, but is independent of any phosphorylation of the enzyme. The effect is complete in about 5 min and is associated with depolymerization of acetyl-CoA carboxylase. Half-maximal inhibition is observed at about 40 nM-CoA. The inhibitory effects of CoA can be partially reversed by incubation with citrate and more fully overcome by treatment of the enzyme with the insulin-stimulated acetyl-CoA carboxylase kinase.

Regulation of mammalian ribonucleotide reductase by the tumor promoters and protein phosphatase inhibitors okadaic acid and calyculin A

1992 ◽  
Vol 70 (10-11) ◽  
pp. 1081-1087 ◽  
Author(s):  
Robert A. R. Hurta ◽  
Jim A. Wright
Keyword(s):  
Okadaic Acid ◽  
Ribonucleotide Reductase ◽  
Protein Phosphatase ◽  
Reductase Activity ◽  
Tumor Promoter ◽  
Calyculin A ◽  
Tumor Promoters ◽  
Phosphatase Inhibitors ◽  
Protein Phosphatase Inhibitors ◽  
Ribonucleotide Reductase Activity

A rapid elevation of ribonucleotide reductase activity was observed with BALB c/3T3 fibroblasts treated with 10 nM okadaic acid, a nonphorbol ester tumor promoter and protein phosphatase inhibitor. Northern blot analysis of the two components of ribonucleotide reductase (R1 and R2) showed a marked elevation of R1 and R2 mRNA expression. Western blot analysis with R1 and R2 specific monoclonal antibodies indicated that the increase in ribonucleotide reductase activity was primarily due to the elevation of the R2 rather than the R1 protein during treatment with okadaic acid. The okadaic acid induced elevations in R1 and R2 message levels occurred without a detectable change in the proportion of cells in S phase and were blocked by treatment of cells with actinomycin D, indicating the importance of the reductase transcriptional process in responding to the action of okadaic acid. Furthermore, down-regulation of protein kinase C with 12-O-tetradecanoylphorbol-13-acetate pretreatment abrogated the okadaic acid mediated elevation of ribonucleotide reductase mRNAs, consistent with the involvement of this signal pathway in the regulation of ribonucleotide reductase and the effects of okadaic acid. Treatment of cells with 2.5 nM calyculin A, another non-phorbol ester tumor promoter and protein phosphatase inhibitor, resulted in a rapid elevation of both R1 and R2 mRNA levels within 10 min of treatment. This first demonstration that the non-phorbol ester tumor promoters and protein phosphatase inhibitors can cause rapid alterations in ribonucleotide reductase gene expression suggests that (i) ribonucleotide reductase, particularly the R2 component, plays a fundamental role in the critical early events involved in the process of tumor promotion, and (ii) illustrates a role for cellular protein phosphatases in the regulation of ribonucleotide reductase and, through this process, the regulation of DNA synthesis.Key words: ribonucleotide reductase, DNA synthesis, okadaic acid, calyculin A, tumor promoter, protein phosphatase.

scholarly journals Effects of the Protein Phosphatase Inhibitors Okadaic Acid and Calyculin A on Insulin Release from Rat Pancreatic Islets.

1992 ◽  
Vol 39 (3) ◽  
pp. 325-329 ◽  
Author(s):  
TATSUO TAMAGAWA ◽  
AKIHISA IGUCHI ◽  
KAZUMASA UEMURA ◽  
HISAYUKI MIURA ◽  
KATSUNORI NONOGAKI ◽  
...  
Keyword(s):  
Pancreatic Islets ◽  
Insulin Release ◽  
Okadaic Acid ◽  
Protein Phosphatase ◽  
Calyculin A ◽  
Phosphatase Inhibitors ◽  
Rat Pancreatic Islets ◽  
Protein Phosphatase Inhibitors

scholarly journals Colorimetric Immuno-Protein Phosphatase Inhibition Assay for Specific Detection of Microcystins and Nodularins of Cyanobacteria

2001 ◽  
Vol 67 (2) ◽  
pp. 904-909 ◽  
Author(s):  
James S. Metcalf ◽  
Steven G. Bell ◽  
Geoffrey A. Codd
Keyword(s):  
Okadaic Acid ◽  
Protein Phosphatase ◽  
Cyclic Peptide ◽  
Calyculin A ◽  
Inhibition Assay ◽  
Specific Detection ◽  
Phosphatase Inhibitors ◽  
Protein Phosphatase Inhibitors ◽  
Protein Phosphatase Inhibition ◽  
Phosphatase Inhibition

ABSTRACT A novel immunoassay was developed for specific detection of cyanobacterial cyclic peptide hepatotoxins which inhibit protein phosphatases. Immunoassay methods currently used for microcystin and nodularin detection and analysis do not provide information on the toxicity of microcystin and/or nodularin variants. Furthermore, protein phosphatase inhibition-based assays for these toxins are not specific and respond to other environmental protein phosphatase inhibitors, such as okadaic acid, calyculin A, and tautomycin. We addressed the problem of specificity in the analysis of protein phosphatase inhibitors by combining immunoassay-based detection of the toxins with a colorimetric protein phosphatase inhibition system in a single assay, designated the colorimetric immuno-protein phosphatase inhibition assay (CIPPIA). Polyclonal antibodies against microcystin-LR were used in conjunction with protein phosphatase inhibition, which enabled seven purified microcystin variants (microcystin-LR, -D-Asp3-RR, -LA, -LF, -LY, -LW, and -YR) and nodularin to be distinguished from okadaic acid, calyculin A, and tautomycin. A range of microcystin- and nodularin-containing laboratory strains and environmental samples of cyanobacteria were assayed by CIPPIA, and the results showed good correlation (R 2 = 0.94, P< 0.00001) with the results of high-performance liquid chromatography with diode array detection for toxin analysis. The CIPPIA procedure combines ease of use and detection of low concentrations with toxicity assessment and specificity for analysis of microcystins and nodularins.

Sign in / Sign up

Export Citation Format

Share Document